Adverse events following immunization of COVID-19 vaccine among children aged 6–11 years

Adverse events following immunization of COVID-19 vaccine among children aged 6–11 years

IntroductionStarting in December 2021, the Indonesian Government has recommended inactivated SARS-CoV-2 vaccine (CoronaVac) for children aged 6–11 years. This study aims to determine the prevalence and determinant factors of adverse events following immunization (AEFI) of the first dose and the seco...

Full description

Bibliographic Details
Main Authors: Fitriana Puspitarani, Mei Neni Sitaresmi, Riris Andono Ahmad
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Public Health
Subjects:
AEFI
COVID-19 vaccine
children
prevalence
determinant factors
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.999354/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2022.999354/full

Similar Items